BHARTIARTL vs SUNPHARMA: Stock Comparison
Bharti Airtel Ltd is the larger company by market capitalisation. Bharti Airtel Ltd shows a higher ROE, a higher dividend yield and faster revenue growth, while Sun Pharmaceutical Industries Ltd shows a lower P/E, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
BHARTIARTL leads 5; SUNPHARMA leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | BHARTIARTL | SUNPHARMA |
|---|---|---|
| Sector | Telecommunication | Healthcare |
| Industry | Telecom - Cellular & Fixed line services | Pharmaceuticals |
Price
| Metric | BHARTIARTL | SUNPHARMA |
|---|---|---|
| Live Price | ₹1,935 | ₹1,910 |
| Day Change | -0.57% | 0.4% |
| Volume | 2.19 L | 23.18 L |
| 52-Week High | ₹2,174.5 | ₹2,046.9 |
| 52-Week Low | ₹1,740.5 | ₹1,548 |
| Distance from 52W High | -11.01% | -6.69% |
Valuation
| Metric | BHARTIARTL | SUNPHARMA |
|---|---|---|
| Market Cap | ₹11.82 L Cr | ₹4.58 L Cr |
| P/E Ratio | 41.04x | 37.71x |
| P/B Ratio | 7.96x | 5.46x |
| EPS | ₹47.87 | ₹50.41 |
| Book Value | ₹259.48 | ₹348.31 |
| Dividend Yield | 1.23% | 0.84% |
Growth
| Metric | BHARTIARTL | SUNPHARMA |
|---|---|---|
| Revenue Growth (TTM YoY) | 15.7% | 12.8% |
| EPS Growth (TTM YoY) | -34% | 25.6% |
| Qtr Sales Growth | 15.7% | 10.5% |
| Qtr Profit Growth | -16.5% | 5.95% |
Profitability & Leverage
| Metric | BHARTIARTL | SUNPHARMA |
|---|---|---|
| ROE | 20.3% | 16% |
| ROCE | 17.6% | 20.5% |
| Net Margin | 14.96% | 18.56% |
| Operating Margin | 55.2% | 29.8% |
| Debt to Equity | 1.31x | 0.06x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | BHARTIARTL | SUNPHARMA |
|---|---|---|
| Promoter Holding | 40.47% | 54.48% |
| FII Holding | 27.12%▼ 0.68 pp | 14.53%▼ 1.4 pp |
| DII Holding | 21.26%▲ 0.61 pp | 22.18%▲ 1.07 pp |
| Public Holding | 2.71%▲ 0.07 pp | 8.81%▲ 0.33 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bharti Airtel Ltd and Sun Pharmaceutical Industries Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.